Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 32, Number 1—January 2026

Research

Enhanced Isolation and Detection of COVID-19 in Hospitalized Patients Undergoing Antiviral Therapy

Ranawaka A.P.M. PereraComments to Author , Andrew Marques, Jevon Graham-Wooten, Li Hui Tan, Noam Cohen, Kyle Rodino, Ronald G. Collman, Frederic D. Bushman, and Susan R. Weiss
Author affiliation: Department of Veterans Affairs, Philadelphia, Pennsylvania, USA (R.A.P.M. Perera); University of Pennsylvania, Philadelphia (R.A.P.M. Perera, A. Marques, J. Graham-Wooten, L.H. Tan, N. Cohen, K. Rodino, R.G. Collman, F.D. Bushman, S.R. Weiss)

Main Article

Table 2

Longitudinal patient cohort demographics from study on the enhanced isolation and detection of COVID-19 in hospitalized patients undergoing antiviral therapy*

Characteristics
 Value
Patients 68
Age range, y
 24–101
Sex
M 23
F
 45
Clinical manifestation
Asymptomatic 10
Symptomatic, survived 54
Symptomatic, died
 4
Vaccinated 38
Nonvaccinated
 30
Antiviral treatment
Remdesivir 27
Paxlovid 3
Monoclonal antibody 6
No antivirals
 7
Immunosuppressed 25

*Values are no. patients except as indicated. Paxlovid, http://www.pfizer.com.

Main Article

Page created: December 30, 2025
Page updated: January 29, 2026
Page reviewed: January 29, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external